糖尿病女性子代特定先天畸形的风险:纳入超8000万例活产的基于人群研究的系统综述与Meta分析
该系统综述与Meta分析纳入59项基于人群的研究、共80,437,056名参与者,评估孕前糖尿病(PGDM)与妊娠期糖尿病(GDM)女性子代总体先天畸形及特定类型先天畸形的风险。结果显示PGDM子代总体先天畸形RR=1.99、先天性心脏病RR=3.46,GDM子代分别为RR=1.18与RR=1.50;PGDM与21类先天畸形风险升高相关,GDM与9类相关。
要点
- PGDM子代总体先天畸形RR=1.99(95%CI 1.82–2.17),先天性心脏病RR=3.46(95%CI 2.77–4.32)。
- GDM子代总体先天畸形RR=1.18(95%CI 1.13–1.23),先天性心脏病RR=1.50(95%CI 1.38–1.64)。
- PGDM与21类先天畸形风险升高相关,GDM与9类相关;PGDM与GDM的RR差异有统计学意义(P<0.001)。
核心结论
- 糖尿病女性子代先天畸形发生率升高,PGDM与GDM的总体先天畸形及先天性心脏病RR存在差异,PGDM子代RR高于GDM子代。
- 作者认为孕期糖尿病筛查可能有助于更好控制血糖,并可能有助于识别先天畸形风险子代。
研究设计与样本
- 系统综述与Meta分析,检索PubMed与Embase自建库至2021年10月15日的基于人群研究,无语言限制。
- 共纳入59项基于人群的研究,发表于1990年至2021年,合计80,437,056名参与者;其中PGDM女性2,407,862名(3.0%),GDM女性2,353,205名(2.9%)。
- 采用随机效应Meta分析、亚组分析与多变量Meta回归,并使用Cochrane偏倚风险工具评估偏倚风险;研究注册于PROSPERO(CRD42021229217)。
主要发现
- PGDM子代总体先天畸形RR=1.99(95%CI 1.82–2.17,P<0.001),先天性心脏病RR=3.46(95%CI 2.77–4.32,P<0.001)。
- GDM子代总体先天畸形RR=1.18(95%CI 1.13–1.23,P<0.001),先天性心脏病RR=1.50(95%CI 1.38–1.64,P<0.001)。
- Meta回归显示PGDM与GDM的先天畸形/先天性心脏病RR差异有统计学意义(均P<0.001)。
- 在23类非先天性心脏病相关先天畸形中,PGDM与21类风险升高相关,RR范围从1.57(尿道下裂,95%CI 1.22–2.02)至18.18(前脑无裂畸形,95%CI 4.03–82.06)。
- GDM与9类先天畸形风险轻度但显著升高相关,RR范围从1.14(肢体短缩,95%CI 1.06–1.23)至5.70(内脏异位,95%CI 1.09–29.92)。
关键数值与推荐
- PGDM子代总体先天畸形RR=1.99(95%CI 1.82–2.17,P<0.001)。
- PGDM子代先天性心脏病RR=3.46(95%CI 2.77–4.32,P<0.001)。
- GDM子代总体先天畸形RR=1.18(95%CI 1.13–1.23,P<0.001)。
- GDM子代先天性心脏病RR=1.50(95%CI 1.38–1.64,P<0.001)。
临床怎么用
- 作者认为孕期糖尿病筛查可能有助于更好控制血糖,并可能有助于识别先天畸形风险子代。
局限性
- 原文指出主要局限性为亚组分析与敏感性分析中仍存在部分高度显著的异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pre-gestational diabetes mellitus (PGDM) has been known to be a risk factor for congenital heart defects (CHDs) for decades. However, the associations between maternal PGDM and gestational diabetes mellitus (GDM) and the risk of specific types of CHDs and congenital anomalies (CAs) in other systems remain under debate. We aimed to investigate type-specific CAs in offspring of women with diabetes and to examine the extent to which types of maternal diabetes are associated with increased risk of CAs in offspring. METHODS AND FINDINGS: We searched PubMed and Embase from database inception to 15 October 2021 for population-based studies reporting on type-specific CAs in offspring born to women with PGDM (combined type 1 and 2) or GDM, with no limitation on language. Reviewers extracted data for relevant outcomes and performed random effects meta-analyses, subgroup analyses, and multivariable meta-regression. Risk of bias appraisal was performed using the Cochrane Risk of Bias Tool. This study was registered in PROSPERO (CRD42021229217). Primary outcomes were overall CAs and CHDs. Secondary outcomes were type-specific CAs. Overall, 59 population-based studies published from 1990 to 2021 with 80,437,056 participants met the inclusion criteria. Of the participants, 2,407,862 (3.0%) women had PGDM and 2,353,205 (2.9%) women had GDM. The meta-analyses showed increased risks of overall CAs/CHDs in offspring born to women with PGDM (for overall CAs, relative risk [RR] = 1.99, 95% CI 1.82 to 2.17, P < 0.001; for CHDs, RR = 3.46, 95% CI 2.77 to 4.32, P < 0.001) or GDM (for overall CAs, RR = 1.18, 95% CI 1.13 to 1.23, P < 0.001; for CHDs, RR = 1.50, 95% CI 1.38 to 1.64, P < 0.001). The results of the meta-regression analyses showed significant differences in RRs of CAs/CHDs in PGDM versus GDM (all P < 0.001). Of the 23 CA categories, excluding CHD-related categories, in offspring, maternal PGDM was associated with a significantly increased risk of CAs in 21 categories; the corresponding RRs ranged from 1.57 (for hypospadias, 95% CI 1.22 to 2.02) to 18.18 (for holoprosencephaly, 95% CI 4.03 to 82.06). Maternal GDM was associated with a small but significant increase in the risk of CAs in 9 categories; the corresponding RRs ranged from 1.14 (for limb reduction, 95% CI 1.06 to 1.23) to 5.70 (for heterotaxia, 95% CI 1.09 to 29.92). The main limitation of our analysis is that some high significant heterogeneity still persisted in both subgroup and sensitivity analyses. CONCLUSIONS: In this study, we observed an increased rate of CAs in offspring of women with diabetes and noted the differences for PGDM versus GDM. The RRs of overall CAs and CHDs in offspring of women with PGDM were higher than those in offspring of women with GDM. Screening for diabetes in pregnant women may enable better glycemic control, and may enable identification of offspring at risk for CAs.
引用
- Zhang TN, Huang XM, Zhao XY, et al. Risks of specific congenital anomalies in offspring of women with diabetes: A systematic review and meta-analysis of population-based studies including over 80 million births. PLoS Med. 2022. PMID: 35104296. doi:10.1371/journal.pmed.1003900
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。